Cancer stem cells in head and neck squamous cell carcinoma: Treatment modalities
Authors:
- Vasileios ZisisVZVasileios Zisis
- Maria VenouMVMaria Venou
- Athanasios PoulopoulosAPAthanasios Poulopoulos
- Dimitrios AndreadisDADimitrios Andreadis
Open Access
- 1 January 2021
- journal article
- review article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Balkan Journal of Dental Medicine
- Vol. 25 (3) , 73-79
Abstract
Head and neck squamous cell carcinoma (HNSCC) belongs to the most frequent cancer subtypes in the world. Mutations due to genetic and chromosomal instability, syndromes such as Fanconi anemia and the Bloom syndrome, environmental risk factors such as tobacco smoking, alcohol and human papillomavirus infection (HPV) subtypes 16,18,31,33,35,52,58 are implicated in its pathogenesis. The HNSCC belongs to the solid tumors of epithelial origin and consists of stromal, inflammatory, cancer cells and most importantly a fraction of them, the cancer stem cells (CSCs). The identification of the CSCs through their biomarkers such as CD44, CD10, CD166, CD133, CD271, ALDH, Oct4, Nanog, Sox2 and Bmi1, the maintenance of their subpopulation through epithelial to mesenchymal transition, the role of HPV infection regarding their prognosis and of their microenvironment regarding their resistance to therapy, all constitute key elements that must be taken thoroughly into consideration in order to develop an effective targeted therapy. There are already therapies in place targeting specific related biomarkers, important biochemical pathways and growth factors. The aim of this literature review is to illustrate the treatment modalities available against the cancer stem cells of head and neck squamous cell carcinoma.Keywords
This publication has 40 references indexed in Scilit:
- Targeting the c-Met/FZD8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous CarcinomasCancer Research, 2014
- c-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cellOral Oncology, 2014
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974Proceedings of the National Academy of Sciences, 2013
- Development of the “Three-step MACS”: a Novel Strategy for Isolating Rare Cell Populations in the Absence of Known Cell Surface Markers from Complex Animal TissueJournal of Biomolecular Techniques : JBT, 2012
- UM‐SCC‐104: A New human papillomavirus‐16–positive cancer stem cell–containing head and neck squamous cell carcinoma cell lineHead & Neck, 2011
- Two stem cell markers, ATP‐binding cassette, G2 subfamily (ABCG2) and BMI‐1, predict the transformation of oral leukoplakia to cancerCancer, 2011
- Head neck squamous cell carcinoma c‐Met+ cells display cancer stem cell properties and are responsible for cisplatin‐resistance and metastasisInternational Journal of Cancer, 2011
- CD44 variant isoforms in head and neck squamous cell carcinoma progressionThe Laryngoscope, 2009
- Cancer Stem Cells in Head and Neck Squamous Cell CancerJournal of Clinical Oncology, 2008
- Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneCancer Cell, 2003